USPTO Patent for Orally Administered Corticosteroid Compositions

The United States Patent and Trademark Office (USPTO) has published a new patent application, US20260083668A1, concerning orally administered corticosteroid compositions. The application, filed on November 28, 2025, by inventors Stephen Perrett, Fredric Jay Cohen, and Gopi M. Venkatesh, describes pharmaceutical compositions and a method for treating gastrointestinal inflammation through the administration of these compositions.

This publication represents a new intellectual property filing and does not impose immediate regulatory obligations on pharmaceutical companies. However, it signifies potential future developments in drug formulations for inflammatory conditions. Companies involved in the development or manufacturing of corticosteroids for oral administration should be aware of this patent filing as it may impact future product development and market exclusivity.